Trial intelligence / Profile preview

Two doses of albumin after large paracentesis in cirrhotics with refractory ascites

2010-019783-37Phase 3Completed

Sponsor
Hospital Trebic
Start
May 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of albumin (human) in Cirrhosis and ascites (2 arms), sponsored by Hospital Trebic. Primary endpoint: survival. Started May 2010; status: completed.

02

Drugs

albumin (human)
03

Conditions

Cirrhosisascites

Beyond the preview

Go deeper on 2010-019783-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019783-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call